Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Wednesday, September 30, 2020.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2020 (2020-09-30): -371.45%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-269.43%
RETURN ON EQUITY (ROE) AVG 3Y
-203.98%
RETURN ON EQUITY (ROE) AVG 5Y
-158.04%
RETURN ON EQUITY (ROE) AVG 10Y
-152.70%
RETURN ON EQUITY (ROE) AVG 15Y
-123.66%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BioCryst Pharmaceuticals, Inc.
Market Cap
$2.06B
Return on Equity (ROE)
N/A
TTM Avg
-269.43%
3Y Avg
-203.98%
5Y Avg
-158.04%
Market Cap
$2.05B
Return on Equity (ROE)
16.36%
TTM Avg
13.19%
3Y Avg
3.41%
5Y Avg
-4.94%
Market Cap
$2.02B
Return on Equity (ROE)
-48.43%
TTM Avg
-97.59%
3Y Avg
-126.46%
5Y Avg
-100.04%
Market Cap
$2.02B
Return on Equity (ROE)
51.09%
TTM Avg
25.46%
3Y Avg
0.90%
5Y Avg
-9.89%
Market Cap
$2.11B
Return on Equity (ROE)
9.17%
TTM Avg
8.21%
3Y Avg
8.13%
5Y Avg
7.80%
Market Cap
$2.01B
Return on Equity (ROE)
-16.25%
TTM Avg
-99.56%
3Y Avg
-48.75%
5Y Avg
-32.00%
Market Cap
$2.00B
Return on Equity (ROE)
-13.09%
TTM Avg
-10.89%
3Y Avg
-18.29%
5Y Avg
-19.41%
Market Cap
$1.97B
Return on Equity (ROE)
-8.14%
TTM Avg
-6.28%
3Y Avg
-6.47%
5Y Avg
-2.03%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals, Inc. (BCRX) | $2.06B | N/A | -269.43% | -203.98% | -158.04% |
| Alvotech (ALVO)vs › | $2.07B | N/A | 23.18% | 49.13% | 48.50% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 16.36% | 13.19% | 3.41% | -4.94% |
| Immunome, Inc. (IMNM)vs › | $2.02B | -48.43% | -97.59% | -126.46% | -100.04% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 51.09% | 25.46% | 0.90% | -9.89% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 9.17% | 8.21% | 8.13% | 7.80% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | -16.25% | -99.56% | -48.75% | -32.00% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -13.09% | -10.89% | -18.29% | -19.41% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -8.14% | -6.28% | -6.47% | -2.03% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -179.99% | -188.10% | 28.98% | -2.67% |
ROE
N/A
ROA
-69.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2020-09-30 | -371.45% |
| 2020-06-30 | -152.17% |
| 2019-12-31 | -284.68% |
| 2019-03-31 | -473.31% |
| 2018-12-31 | -205.65% |
| 2018-09-30 | -128.12% |
| 2018-06-30 | -170.84% |
| 2018-03-31 | -124.63% |
| 2017-12-31 | -78.53% |
| 2017-09-30 | -50.42% |
| 2017-06-30 | -195.78% |
| 2017-03-31 | -120.77% |
| 2016-06-30 | -536.86% |
| 2016-03-31 | -182.34% |
| 2015-12-31 | -90.14% |
| 2015-09-30 | -57.08% |
| 2015-06-30 | -40.30% |
| 2015-03-31 | -78.01% |
| 2014-12-31 | -59.75% |
| 2014-09-30 | -46.67% |
| 2014-06-30 | -42.42% |
| 2012-09-30 | -421.30% |
| 2012-06-30 | -293.63% |
| 2012-03-31 | -215.87% |
| 2011-12-31 | -384.63% |
| 2011-09-30 | -207.20% |
| 2011-06-30 | -128.26% |
| 2011-03-31 | -81.75% |
| 2010-12-31 | -51.68% |
| 2010-09-30 | -11.43% |
| 2010-06-30 | -9.88% |
| 2010-03-31 | -7.90% |
| 2009-12-31 | -15.59% |
| 2009-09-30 | -78.71% |
| 2009-06-30 | -54.02% |
| 2009-03-31 | -54.33% |
| 2008-12-31 | -53.27% |
| 2008-09-30 | -105.93% |
| 2008-06-30 | -92.11% |
| 2008-03-31 | -61.47% |
| 2007-12-31 | -44.77% |
| 2007-09-30 | -56.12% |
| 2007-06-30 | -443.55% |
| 2007-03-31 | -318.45% |
| 2006-12-31 | -206.18% |
| 2006-09-30 | -135.66% |
| 2006-06-30 | -73.82% |
| 2006-03-31 | -53.24% |
| 2005-12-31 | -44.66% |
| 2005-09-30 | -70.42% |
| 2005-06-30 | -53.54% |
| 2005-03-31 | -45.77% |
| 2004-12-31 | -71.94% |
| 2004-09-30 | -55.56% |
| 2004-06-30 | -43.59% |
| 2004-03-31 | -35.40% |
| 2003-12-31 | -44.64% |
| 2003-09-30 | -39.55% |
| 2003-06-30 | -35.69% |
